CliniRx Research

What CliniRx Research does

CliniRx Research Private Limited is a privately held global Contract Research Organization (CRO) headquartered in New Delhi, India, and operating through wholly-owned subsidiaries in 10 countries: the United States (Bridgewater, NJ), United Kingdom (London), India (New Delhi), Australia, Hong Kong, Singapore, Spain (Barcelona), the Netherlands (Amsterdam), Mexico (Mexico City), and Argentina (Buenos Aires). The company is a subsidiary of JK Group, a diversified multinational conglomerate with a 125-year legacy and approximately $4 billion in annual revenue. Founded circa 2015, CliniRx employs 101-250 people and delivers clinical development services for small and mid-size biotech and pharmaceutical sponsors across Phase 1 to Phase 4 studies.

The company delivers its services through two core models: a Full-Service CRO offering that integrates Regulatory Affairs, Clinical Operations, Biometrics, Project Management, Medical Affairs, Quality Assurance, and Pharmacovigilance for end-to-end trial management, and a Functional Service Provider (FSP) model that provides flexible scientific and operational resourcing across nine functional areas. Supporting technology includes EDC-based clinical data management, SAS/R statistical programming, and CDISC-compliant dataset creation (SDTM, SEND, ADaM) for regulatory submissions. Therapeutic area depth spans neurology, oncology, psychiatry, rare diseases, cardiovascular/metabolic, infectious disease, gastroenterology, and ophthalmology.

CliniRx generates revenue through professional services engagements sold via direct enterprise sales, with prospective clients directed to submit RFI/RFP through the company website. Pricing is not publicly disclosed and is custom-quoted based on study scope, phase, geography, and duration. Demand generation relies primarily on thought-leadership content, industry conferences (SCOPE Summit, OCT West Coast/East Coast), and LinkedIn/X social presence. The company is privately held with no disclosed funding rounds, M&A activity, or revenue figures.

Name

CliniRx Research

Legal name

CliniRx Research Private Limited

Website

https://clinirx.com

Company type

Private

Founded year

2015

Operating status

Operating

Headcount range

101–250 employees

Short description

CliniRx Research is a privately held global Contract Research Organization, backed by India's JK Group, that delivers Full-Service CRO and Functional Service Provider (FSP) clinical trial services across Phase 1-4 studies for small and mid-size biotech and pharmaceutical sponsors, operating through subsidiaries in 10 countries.

Ownership category

akta.pro rank

Product category

Contract Research Organization (CRO) Services

NAICS

Scientific Research and Development Services (5417)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Clinical CROs (Phase I–IV) (HLAGAAAA)

akta.pro secondary industries

Clinical Data Management, Biostatistics & Statistical Programming CROs (HLAGAAAF), Pharmacovigilance, Risk Management & Medical Affairs CROs (HLAGAAAH), Medical Writing & Regulatory Submission Support CROs (HLAGAAAG)

Keywords

• Clinical research services
• Contract research organization
• Functional service provider
• Clinical trial management
• Biometrics services

Headquarters

HQ city

New Delhi

HQ country

India

HQ region

Asia

Offices10 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Full-Service CRO Services: Comprehensive end-to-end clinical trial management including regulatory affairs, clinical operations, biometrics, project management, medical affairs, and quality assurance for biotech and pharma sponsors.
2. Functional Service Provider (FSP) Model: Strategic resourcing providing skilled scientific and clinical experts who seamlessly integrate with sponsor in-house teams, processes, and environments, offering flexibility for small to mid-sized biotech organizations facing resource constraints.

Go-to-market motion2 records

Distribution channels2 records

Marketing channels5 records

Core offering

CliniRx Research provides global clinical research services as a Contract Research Organization (CRO), delivering end-to-end clinical trial management via a Full-Service CRO model and on-demand scientific resourcing via a Functional Service Provider (FSP) model. Services span Regulatory Affairs, Clinical Operations, Biometrics, Project Management, Medical Affairs, Quality Assurance, and Pharmacovigilance for Phase I-IV clinical trials across North America, Europe, Asia-Pacific, and Latin America. The company serves small and mid-size biotech and pharmaceutical sponsors, including therapeutic area specialization in neurology, oncology, rare diseases, psychiatry, and metabolic disorders.

Product overview

CliniRx Research operates as a global Contract Research Organization (CRO) providing clinical development services through two core delivery models: Full-Service CRO and Functional Service Provider (FSP). The Full-Service CRO model integrates all disciplines (Regulatory Affairs, Clinical Operations, Biometrics, Project Management, Medical Affairs, Quality Assurance, and Pharmacovigilance) for end-to-end Phase 2-4 clinical trial management. The FSP model offers flexible resourcing solutions across nine functional areas including site management, biostatistics, vendor management, statistical programming, project management, clinical safety/pharmacovigilance, site monitoring, regulatory affairs, and clinical data management. The company also provides specialized therapeutic area expertise in Neurology (Parkinson's, Ataxia Telangiectasia, TBI, Rett Syndrome), Psychiatry (Schizophrenia, Bipolar Disorder), Oncology (Breast Cancer, NSCLC, Prostate Cancer), Cardiovascular/Metabolic Diseases, Infectious Diseases, Gastroenterology, and Ophthalmology. Supported by the 125-year legacy of parent company JK Group, CliniRx maintains offices across USA, UK, Netherlands, Spain, Hong Kong, India, and Australia.

Differentiator

Problem solved

Functional benefit

Products and services

• Full-Service CRO End-to-end clinical trial management service integrating all disciplines (Regulatory Affairs, Clinical Operations, Biometrics, Project Management, Medical Affairs, Quality Assurance, Pharmacovigilance) for Phase II-IV studies for biotech and pharma sponsors globally.
• Functional Service Provider (FSP) Strategic resourcing solution providing skilled scientific talent across site management, biostatistics, vendor management, statistical programming, project management, clinical safety/pharmacovigilance, site monitoring, regulatory affairs, and clinical data management functions, integrating with sponsor in-house teams.
• Global Regulatory Affairs Regulatory strategy and submission services spanning pre-clinical through post-marketing phases, including eCTD creation and publishing, safety reporting (DSUR, PSUR), and country-specific registrations for biotech and pharma sponsors.
• Clinical Operations Site selection, feasibility assessments, site management, clinical monitoring, and vendor management services ensuring protocol adherence and ICH-GCP compliance throughout trial execution.
• Biometric Services Integrated data management and biostatistics services including clinical data management via EDC platforms, statistical programming (SAS/R), and CDISC-compliant dataset creation (SDTM, SEND, ADaM) for regulatory submissions.
• Clinical Project Management Project planning, coordination, and execution services managing cross-functional teams (regulatory, clinical monitors, data managers, site personnel) across timelines and budgets while maintaining quality and compliance standards.
• Global Medical Affairs Medical monitoring and support services including protocol design, endpoint selection, site selection, on-site medical monitoring, patient data review, safety management, and post-study CSR reviews.
• Quality Assurance Independent quality assurance services including compliance monitoring against ICH-GCP guidelines, risk management, SOP development, inspection-readiness support, vendor audits, and QMS implementation.
• Clinical Safety and Pharmacovigilance Safety monitoring and adverse event reporting services including safety database management, signal detection, regulatory authority safety reporting (DSURs), and Data Monitoring Committee collaboration.

Quantifiable outcome

• India contributed 25% of eligible patient enrollment for a Phase IIB Tuberous Sclerosis Complex study within one year, becoming the highest recruiting country at enrollment completion.
• +1 more outcomes

Named customers2 records

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators2 records

Recent moves5 records

Expansion highlights5 records

Broad incumbents

• ICON plc: Large global CRO offering full-service clinical and FSP solutions across all major therapeutic areas. Competes with CliniRx on enterprise biotech accounts but with broader scale and integrated lab/data services.
• Syneos Health: Global clinical and commercial CRO serving biotech and pharma across full-service and FSP. Direct overlap with CliniRx's hybrid delivery model and customer segments.
• Parexel International: Major global CRO (now under EQT-Pamplona ownership) operating across Phase I-IV and FSP. Overlaps directly with CliniRx in regulatory affairs, biometrics, and clinical operations delivery for biotech sponsors.
• IQVIA: The largest global CRO with integrated R&D technology, real-world evidence, and FSP capabilities. Competes with CliniRx for biotech sponsors and sets pricing benchmarks in the mid-tier CRO market.
• Fortrea (formerly Labcorp Drug Development): Large global CRO spun out from Labcorp, offering full-service clinical and FSP across all phases. Directly comparable delivery model and overlapping biotech/biopharma customer base.

Direct peers

• Worldwide Clinical Trials: Mid-size global CRO with therapeutic-area specialization in neuroscience, rare disease, and oncology. Operates a similar full-service + FSP hybrid model serving small and mid-size biotech sponsors.
• Medpace: Mid-size CRO focused on small and mid-size biotech sponsors with therapeutic-area-led delivery model. Highly comparable to CliniRx in customer profile and FSP-style resourcing, though materially larger in scale and revenue.

Emerging players

• Veristat: Smaller specialized CRO focused on biostatistics, clinical data management, and regulatory submission support for small-mid biotech. Comparable to CliniRx's biometric and regulatory affairs service modules.
• Clinipace Worldwide: Smaller mid-size CRO with technology-enabled clinical trial services for small and mid-size biotech. Comparable target customer profile and therapeutic area focus.

Regional players

• Tigermed: Leading China-headquartered CRO with growing international presence, offering clinical trial services across Asia and globally. Comparable scale and emerging-market cost positioning, though primarily serving Asia-Pacific.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/clinirx
• LinkedInlinkedin.com/company/clinirx-research
• Facebookfacebook.com/profile.php

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries10 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CliniRx Research